CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Lymphoma, specifically an aggressive form of non-Hodgkin's lymphoma, is one of the most common types of cancer and one of the top ten cancer killers. The other major type of lymphoma is Hodgkin's disease. Hodgkin's disease is less common, but is easier to treat and cure than aggressive forms of non-Hodgkin's lymphoma.